highlighted in morgans life sciences index

Scott Power of Morgans has highlighted QRX as one of two biotech stocks to seek out because of significant near-term news flows:

http://www.morgans.com.au/Blog/2014/April/Morgans-Life-Science-Index.aspx

To quote:

"The Morgans Life Sciences Index...(like the NASDAQ Biotech Index) is retracing after a very good run through the second half of 2013. As the Index becomes increasingly stock-specific and patchy, seek out companies with near-term positive news flow. Two such companies are Qrxpharma Ltd - QRX (Advisory Committee meeting this month to discuss and recommend MOXDUO) and Neuren Pharmaceutical - NEU (completing recruitment for Retts Phase 2 trial in 2QCY14)."